Literature DB >> 19622041

Increased activity of Coxsackievirus B1 strains associated with severe disease among young infants in the United States, 2007-2008.

Mary E Wikswo1, Nino Khetsuriani, Ashley L Fowlkes, Xiaotian Zheng, Silvia Peñaranda, Natasha Verma, Stanford T Shulman, Kanta Sircar, Christine C Robinson, Terry Schmidt, David Schnurr, M Steven Oberste.   

Abstract

BACKGROUND: Enterovirus infections are very common and typically cause mild illness, although neonates are at higher risk for severe illness. In 2007, the Centers for Disease Control and Prevention (CDC) received multiple reports of severe neonatal illness and death associated with coxsackievirus B1 (CVB1), a less common enterovirus serotype not previously associated with death in surveillance reports to the CDC.
METHODS: This report includes clinical, epidemiologic, and virologic data from cases of severe neonatal illness associated with CVB1 reported during the period from 2007 through 2008 to the National Enterovirus Surveillance System (NESS), a voluntary, passive surveillance system. Also included are data on additional cases reported to the CDC outside of the NESS. Virus isolates or original specimens obtained from patients from 25 states were referred to the CDC picornavirus laboratory for molecular typing or characterization.
RESULTS: During 2007-2008, the NESS received 1079 reports of enterovirus infection. CVB1 accounted for 176 (23%) of 775 reported cases with known serotype, making it the most commonly reported serotype for the first time ever in the NESS. Six neonatal deaths due to CVB1 infection were also reported to the CDC during that time. Phylogenetic analysis of the 2007 and 2008 CVB1 strains indicated that the increase in cases resulted from widespread circulation of a single genetic lineage that had been present in the United States since at least 2001.
CONCLUSIONS: Healthcare providers and public health departments should be vigilant to the possibility of continuing CVB1-associated neonatal illness, and testing and continued reporting of enterovirus infections should be encouraged.

Entities:  

Mesh:

Year:  2009        PMID: 19622041     DOI: 10.1086/605090

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  26 in total

1.  Discovery of Structurally Diverse Small-Molecule Compounds with Broad Antiviral Activity against Enteroviruses.

Authors:  Jun Zuo; Steve Kye; Kevin K Quinn; Paige Cooper; Robert Damoiseaux; Paul Krogstad
Journal:  Antimicrob Agents Chemother       Date:  2015-12-28       Impact factor: 5.191

2.  Detection of Enteroviruses in Influent and Effluent Flow Samples from Wastewater Treatment Plants in Italy.

Authors:  Andrea Battistone; Gabriele Buttinelli; Paolo Bonomo; Stefano Fiore; Concetta Amato; Pietro Mercurio; Antonella Cicala; Josef Simeoni; Adelheid Foppa; Maria Triassi; Francesca Pennino; Lucia Fiore
Journal:  Food Environ Virol       Date:  2013-11-26       Impact factor: 2.778

3.  Molecular determinants of disease in coxsackievirus B1 murine infection.

Authors:  Javier O Cifuente; María F Ferrer; Carolina Jaquenod de Giusti; Wen-Chao Song; Víctor Romanowski; Susan L Hafenstein; Ricardo M Gómez
Journal:  J Med Virol       Date:  2011-09       Impact factor: 2.327

4.  Neural stem cell depletion and CNS developmental defects after enteroviral infection.

Authors:  Chelsea M Ruller; Jenna M Tabor-Godwin; Donn A Van Deren; Scott M Robinson; Sonia Maciejewski; Shea Gluhm; Paul E Gilbert; Naili An; Natalie A Gude; Mark A Sussman; J Lindsay Whitton; Ralph Feuer
Journal:  Am J Pathol       Date:  2011-12-31       Impact factor: 4.307

5.  Poliovirus and Other Enteroviruses from Environmental Surveillance in Italy, 2009-2015.

Authors:  Roberto Delogu; Andrea Battistone; Gabriele Buttinelli; Stefano Fiore; Stefano Fontana; Concetta Amato; Karen Cristiano; Sabine Gamper; Josef Simeoni; Rita Frate; Laura Pellegrinelli; Sandro Binda; Licia Veronesi; Roberta Zoni; Paolo Castiglia; Andrea Cossu; Maria Triassi; Francesca Pennino; Cinzia Germinario; Viviana Balena; Antonella Cicala; Pietro Mercurio; Lucia Fiore; Carlo Pini; Paola Stefanelli
Journal:  Food Environ Virol       Date:  2018-06-12       Impact factor: 2.778

Review 6.  Virus infections and type 1 diabetes risk.

Authors:  Merja Roivainen; Karin Klingel
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

7.  Large-Scale Survey of Human Enteroviruses in Wastewater Treatment Plants of a Metropolitan Area of Southern Italy.

Authors:  Francesca Pennino; Antonio Nardone; Paolo Montuori; Sara Aurino; Ida Torre; Andrea Battistone; Roberto Delogu; Gabriele Buttinelli; Stefano Fiore; Concetta Amato; Maria Triassi
Journal:  Food Environ Virol       Date:  2017-12-16       Impact factor: 2.778

8.  Phylogenetic patterns of human coxsackievirus B5 arise from population dynamics between two genogroups and reveal evolutionary factors of molecular adaptation and transmission.

Authors:  Cécile Henquell; Audrey Mirand; Jan Richter; Isabelle Schuffenecker; Blenda Böttiger; Sabine Diedrich; Elena Terletskaia-Ladwig; Christina Christodoulou; Hélène Peigue-Lafeuille; Jean-Luc Bailly
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

9.  Fluoxetine is a potent inhibitor of coxsackievirus replication.

Authors:  Jun Zuo; Kevin K Quinn; Steve Kye; Paige Cooper; Robert Damoiseaux; Paul Krogstad
Journal:  Antimicrob Agents Chemother       Date:  2012-07-02       Impact factor: 5.191

Review 10.  Enteroviruses in the early 21st century: new manifestations and challenges.

Authors:  Debra Lugo; Paul Krogstad
Journal:  Curr Opin Pediatr       Date:  2016-02       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.